Insmed
INSM
#1050
Rank
โ‚น2.218 T
Marketcap
โ‚น10,236
Share price
-0.17%
Change (1 day)
16.30%
Change (1 year)

Revenue for Insmed (INSM)

Revenue in 2026 (TTM): โ‚น74.14 Billion

According to Insmed's latest financial reports the company's current revenue (TTM ) is โ‚น78.59 Billion. In 2025 the company made a revenue of โ‚น54.43 Billion an increase over the revenue in the year 2024 that were of โ‚น31.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Insmed from 2000 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น74.14 B36.19%
2025 โ‚น54.43 B74.47%
2024 โ‚น31.20 B22.8%
2023 โ‚น25.40 B25.14%
2022 โ‚น20.30 B44.74%
2021 โ‚น14.02 B16.66%
2020 โ‚น12.02 B23.56%
2019 โ‚น9.73 B1315.12%
2018 โ‚น0.68 B
2017 N/A
2016 N/A
2015 N/A
2014 N/A-100%
2013 โ‚น0.71 B
2012 N/A-100%
2011 โ‚น0.23 B-24.66%
2010 โ‚น0.31 B-35.57%
2009 โ‚น0.48 B-15.82%
2008 โ‚น0.57 B94.95%
2007 โ‚น0.29 B567.52%
2006 โ‚น43.93 M645.3%
2005 โ‚น5.89 M-0.64%
2004 โ‚น5.93 M-13.12%
2003 โ‚น6.82 M-92.72%
2002 โ‚น93.75 M556.41%
2001 โ‚น14.28 M-1192.92%
2000 -โ‚น1.31 Million

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚น5.425 T 6,803.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น2.851 T 3,528.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1.171 T 1,390.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น209.46 B 166.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น20.51 B-73.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น115.57 B 47.05%๐Ÿ‡บ๐Ÿ‡ธ USA